Skip to main content

Table 2 Comparison of clinical variables and radiomics score in the responding group and non-responding group in the training cohort

From: CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer

Factors

Responding group

Non-responding group

P value

Age (years, mean ± SD)

56.76 ± 11.42

52.85 ± 11.91

0.02

Gender

  

1.00

 Male

24

24

 

 Female

13

13

 

BMI (kg/m2)

21 ± 3

21 ± 4

0.42

AFP (ng/mL)

8.95 ± 13.51

7.86 ± 17.55

0.56

CEA (IU/L)

  

0.80

 Normal

26

24

 

 Elevated

11

13

 

CA199 (IU/L)

  

1.00

 Normal

32

32

 

 Elevated

5

5

 

CA125 (IU/L)

  

1.00

 Normal

36

37

 

 Elevated

1

0

 

Preoperative T stage

  

0.17

 2

0

1

 

 3

8

3

 

 4

29

33

 

Preoperative N status

  

0.19

 0

2

0

 

 1

13

8

 

 2

18

21

 

 3

4

8

 

Preoperative M status

  

0.05

 0

28

19

 

 1

9

18

 

Radiomics score

0.54 ± 0.22

0.41 ± 0.22

< 0.01

  1. Abbreviations: BMI body mass index, PS performance status, AFP alpha-fetoprotein, CEA carcinoembryonic antigen